Sign in to fuzzto save your conversations, follow your research and come back anytime.
Sudarshan Pharma Industries
SectorChemicals
| Metric (₹ crore) | Q4 FY24 | Q1 FY25 | Q2 FY25 | Q3 FY25 | Q4 FY25 | Q1 FY26 | Q2 FY26 | Q3 FY26 | Q4 FY26 | Q1 FY27 |
|---|---|---|---|---|---|---|---|---|---|---|
| Sales | 231.74 | 99.2 | 128.58 | 115.66 | 161.59 | 145.26 | 168.87 | 168.01 | 220.92 | 174.42 |
| Expenses | 217.33 | 97.12 | 115.54 | 107.68 | 145.66 | 134.22 | 159.66 | 157.14 | 200.72 | 158.52 |
| EBITDA | 14.41 | 2.08 | 13.04 | 7.98 | 15.93 | 11.04 | 9.21 | 10.87 | 20.2 | 15.9 |
| Depreciation | 0.64 | 0.67 | 0.67 | 0.63 | 0.83 | 0.88 | 0.9 | 0.91 | 1.09 | 1.41 |
| EBIT | 13.77 | 1.41 | 12.37 | 7.35 | 15.1 | 10.16 | 8.31 | 9.96 | 19.11 | 14.49 |
| Interest | 5.73 | 3.94 | 3.7 | 4 | 4.4 | 5.96 | 5.94 | 6.28 | 7.53 | 8.21 |
| Profit Before Tax | 8.04 | -2.53 | 8.67 | 3.35 | 10.7 | 4.2 | 2.37 | 3.68 | 11.58 | 6.28 |
| Net Profit | 6.6 | -1.21 | 5.88 | 2.88 | 7.41 | 3.96 | 3.87 | 4.15 | 11.39 | 5.61 |
| EPS | 0.27 | -0.05 | 0.24 | 0.12 | 0.29 | 0.16 | 0.16 | 0.18 | 0.48 | 0.23 |
| Metric (₹ crore) | FY20 | FY21 | FY22 | FY23 | FY24 | FY25 | FY26 |
|---|---|---|---|---|---|---|---|
| Operating Cash Flow | 0.51 | 2.77 | -3.82 | -28.79 | 6.01 | -32.32 | -2.3 |
| Investing Cash Flow | -2.53 | -1.29 | -1.46 | -25.65 | -5.49 | -20.62 | -76.29 |
| Financing Cash Flow | -0.28 | -1.49 | 4.26 | 65.93 | -12.1 | 53.35 | 79.17 |
| Net Cash Flow | -2.3 | -0.01 | -1.02 | 11.49 | -11.58 | 0.41 | 0.58 |
| Metric (₹ crore) | FY20 | FY21 | FY22 | FY23 | FY24 | FY25 | FY26 |
|---|---|---|---|---|---|---|---|
| Equity / Shareholders' Funds | 19.84 | 22.56 | 29.78 | 100.97 | 111.71 | 131.48 | 156.32 |
| Total Liabilities | 38.31 | 76.7 | 107.75 | 131.5 | 171.42 | 270.93 | 485.43 |
| Total Assets | 58.14 | 99.26 | 137.52 | 232.48 | 283.12 | 402.41 | 641.75 |